


Reverra Therapeutics Revenue
Biotechnology Research • • 1-10 Employees
Reverra Therapeutics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at Reverra Therapeutics
Muhammad Yusuf Atthariq Azof
Co-Founder
Company overview
| Headquarters | XX |
| NAICS | 541714 |
| Founded | 2025 |
| Employees | 1-10 |
About Reverra Therapeutics
At Reverra Therapeutics, we are developing a novel immunotherapeutic platform for Alzheimer’s disease. Our mission is to enable safer, more effective treatment by addressing key challenges in delivery, clearance of pathological proteins, and long-term disease suppression. Grounded in cutting-edge science and translational research, we aim to redefine the future of neurodegenerative disease therapy. For enquiries, reach us at reverra.bio@gmail.com
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Reverra Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Reverra Therapeutics has never raised funding before.
Frequently asked questions
4.8
40,000 users



